Show simple item record

dc.date.accessioned2012-06-26T01:39:33Z
dc.date.available2012-06-26T01:39:33Z
dc.date.created2003en
dc.date.issued2003en
dc.identifier.urihttps://iris.who.int/handle/10665/72391
dc.language.isoen
dc.subject.meshCanadaen
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleRecombinant antihaemophilic factor: dose monitoring requireden
dc.typeJournal / periodical articles
dc.relation.ispartofjournalWHO drug information 2003 ; 17(‎4)‎ : 251


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record